Physicians Total Care Recalls Cephalexin Capsules Due to Manufacturing Deviations
Physicians Total Care is recalling specific lots of Cephalexin Monohydrate Capsules because the active ingredients were not manufactured with good manufacturing practices.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The source cites CGMP deviations regarding the manufacturing of active ingredients but does not report specific illnesses, injuries, or fatalities, fitting the criteria for a moderate severity precautionary recall.
Plain-English summary
Physicians Total Care, Inc. is recalling 340 capsules (17 bottles containing 20 capsules each) of Cephalexin Monohydrate Capsules, USP, 500 mg. The affected products are prescription-only and were distributed in Georgia and Missouri. The recall involves lot codes 79MI, 79SF, and 7AH5, all with expiration dates in 2015.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the active pharmaceutical ingredients used in these products were not manufactured in accordance with good manufacturing practices. This deviation raises concerns about the quality and consistency of the medication.
Consumers who have these specific bottles should stop using the medication and contact their healthcare provider or pharmacist for guidance. The product was manufactured for Caraco Pharmaceuticals by Sun Pharmaceuticals and repackaged by Physicians Total Care, Inc.
The recalled product
- Product
- CEPHALEXIN MONOHYDRATE CAPSULES,USP, 500 mg, 20-count bottle, Rx only, Manufactured for Caraco Pharmaceuticals, Detroit, MI 48202 by Sun Pharmaceuticals, Fort Worth, TX 76155 and repackaged by Physicians Total Care, Inc., Tulsa, OK 74146-6233
- Manufacturer
- Physicians Total Care, Inc.
- Category
- Drug — Antibiotic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot Code: 79MI (Exp. Date 01/31/2015)
- 79SF (Exp. Date 01/31/2015)
- 7AH5 (Exp. Date 06/30/2015)
Distribution
Related recalls
Same manufacturer · Physicians Total Care, Inc.
See all →- LowPhysicians Total Care Recalls Loratadine Tablets Due to Chipped or Broken Pieces
FDA (Drugs) · 2014-11-12
- SeverePhysicians Total Care Recalls Carisoprodol Tablets Due to Foreign Substance
FDA (Drugs) · 2014-01-01
- ModeratePhysicians Total Care Recalls Belladonna Alkaloids Tablets Due to Foreign Substance
FDA (Drugs) · 2013-08-07
- LowVoltaren 1% Gel Recalled for Illegible Lot and Expiration Dates
FDA (Drugs) · 2013-06-12
- ModeratePhysicians Total Care Recalls Metronidazole Tablets for Weight Specification Failures
FDA (Drugs) · 2013-06-12
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateCaraco Recalls Cephalexin Capsules Due to Manufacturing Practice Deviations
FDA (Drugs) · 2014-08-13
- ModerateCaraco Recalls Cephalexin Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2014-08-13
- ModeratePhysicians Total Care Tetracycline Recalled for Potential Foreign Particulate Matter
FDA (Drugs) · 2013-04-03
- SevereSun Pharmaceutical Recalls Doxycycline Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2020-03-25
- SeverePhysicians Total Care Recalls Subpotent Levothyroxine Tablets
FDA (Drugs) · 2013-03-27
- ModerateLupin Recalls Cephalexin Oral Suspension Due to Missing Manufacturing Records
FDA (Drugs) · 2019-01-23